FDA Approves First Drug for Duchenne Muscular Dystrophy
This morning the FDA announced its approval of eteplirsen (brand name, Exonys 51) for the treatment of Duchenne muscular dystrophy (DMD) in boys “who have a...
Read MoreThis morning the FDA announced its approval of eteplirsen (brand name, Exonys 51) for the treatment of Duchenne muscular dystrophy (DMD) in boys “who have a...
Read MoreThe bottle contained…a reddish, somewhat viscous liquid, having an aromatic odor resembling raspberry and anise, a sweet taste, and resembling glycerin in general...
Read More